J Gynecol Oncol.  2009 Jun;20(2):72-76. 10.3802/jgo.2009.20.2.72.

Current status of gynecological cancer in China

• Kim K
• Zang R
• Choi SC
• Ryu SY
• Kim JW

• KMID: 2245084
• DOI: http://doi.org/10.3802/jgo.2009.20.2.72

Abstract

The aim of this review is to examine the current status of gynecological cancer in China focusing on epidemiological data. Epidemiological data on gynecological cancer in China is sparse. Therefore, most of the data were estimated via extrapolation based on a few available datasets. Cervical cancer is relatively rare and the incidence and mortality rate are largely decreasing. However, in young women, the incidence and mortality rates are increasing. The overall and age-specific incidence rates of cervical cancer appear to be varied according to geographical areas. The overall prevalence rate of human papillomavirus (HPV) in China is similar with other eastern Asian countries, but the age-specific HPV prevalence showed sustained high HPV prevalence rates in elderly women. There is not yet an established national program for cervical cancer prevention. The incidence rate of corpus and ovarian cancers in China slightly increased between 2000 and 2005, but is still lower than Japan or Korea. There is no reliable, national-level data on mortality rates of corpus and ovarian cancer in China. Breast cancer is one of the most rapidly increasing cancers in China. The increase was sharper in young women than in elderly women. Both increased risk and change of population size/structure contributed to the increase of breast cancer.

Keyword

Uterine cervical neoplasm; Endometrial neoplasm; Ovarian neoplasm; Breast neoplasm; China; Epidemiology

MeSH Terms

Aged
Asian Continental Ancestry Group
Breast Neoplasms
China
Endometrial Neoplasms
Female
Humans
Incidence
Japan
Korea
Ovarian Neoplasms
Prevalence
Uterine Cervical Neoplasms

Figure

• 

  Fig. 1 The incidence of gynecological cancers in Shanghai, China.

Reference

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006. 24:2137–2150.

2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005. 55:74–108.

3. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001. 94:153–156.

4. Country Cooperation Strategy at a glance, China [Internet]. WHO. c2003-2005. cited 2009 May 29. Geneva: World Health Organization;Available from http://www.who.int/countries/chn/en/.

5. Yang L, Parkin DM, Ferlay J, Li L, Chen Y. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev. 2005. 14:243–250.

6. Yang L, Parkin DM, Li L, Chen Y. A comparison of the sources of cancer mortality in China. Cancer Causes Control. 2004. 15:681–687.

7. Yang L, Parkin DM, Li L, Chen Y. Time trends in cancer mortality in China: 1987-1999. Int J Cancer. 2003. 106:771–783.

8. Yang L, Parkin DM, Whelan S, Zhang S, Chen Y, Lu F, et al. Statistics on cancer in China: cancer registration in 2002. Eur J Cancer Prev. 2005. 14:329–335.

9. IARC: Cancer Epidemiology Database, GLOBOCAN 2002 [Internet]. c2002. cited 2009 May 29. Lyon: International Agency for Research on Cancer;Available from http://www-dep.iarc.fr/.

10. Shi JF, Qiao YL, Smith JS, Dondog B, Bao YP, Dai M, et al. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia. Vaccine. 2008. 26:Suppl 12. M53–M59.

11. Yang L, Parkin DM, Li LD, Chen YD, Bray F. Estimation and projection of the national profile of cancer mortality in China 1991-2005. Br J Cancer. 2004. 90:2157–2166.

12. Zhao F, Li N, Ma J. Study of the association between human papillomavirus infection and cervical cancer in Xianguan county, Shanxi province. Zhonghua Liu Xing Bing Xue Za Zhi. 2001. 22:375–378.

13. Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, et al. Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer. 2007. 121:1306–1311.

14. Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer. 2006. 119:2677–2684.